Table 2 Comparison of patients who presented absence of or a decrease in the level of fatigue on HD day (Improved group) with those who did not present decrease in the level of fatigue (Non-improved group) at baseline as compared to 8th week
Improved group (I) | (n = 64) | Non-improved group (M) | (n = 41) | Group I versus N | |||
|---|---|---|---|---|---|---|---|
Ow | 8w | p value | Ow | 8w | p value | ||
NRS on HD day | 3.51 ± 2.66 | 2.09 ± 1.98 | 0.00 | 3.75 ± 2.35 | 5.65 ± 2.12 | 0.00 | Ow: 0.62, 8w: 0.00 |
NRS on HD-free day | 1.65 ± 1.87 | 1.23 ± 1.46 | 0.03 | 2.12 ± 1.74 | 3.41 ± 1.80 | 0.00 | Ow: 0.19, 8w: 0.00 |
Age (years) | 65.3 ± 11.9 | 68.4 ± 10.7 | 0.18 | ||||
HD vintage (months) | 103 ± 99 | 136 ± 121 | 0.12 | ||||
Male (%) | 39 (60.9%) | 22 (53.7%) | 0.59 | ||||
DM | 38 (59.4%) | 21 (51.2%) | 0.53 | ||||
CVD | 21(32.8%) | 13 (31.7%) | 0.99 | ||||
AHA | 33 (51.6%) | 30 (46.9%) | 0.72 | 28 (68.3%| | 28 (68.3%) | 1.00 | Ow: 0.13, 8w: 0.05 |
UF(L) | 2.8 ± 0.7 | 2.8 ± 0.6 | 0.65 | 2.6 ± 0.7 | 2.6 ± 0.6 | 0.82 | Ow.0.12 |
Dry weight (kg) | 61.7 ± 15.0 | 61.8 ± 14.9 | 0.32 | 55.0 ± 14.2 | 56.5 ± 12.2 | 0.37 | Ow: 0.02 |
CTR (%) | 48.5 ± 5.1 | 47.9 ± 4.8 | 0.04 | 46.4 ± 3.8 | 46.5 ± 5.1 | 0.80 | Ow: 0.03 |
Pre-SBP (mmHg) | 160 ± 27 | 155 ± 26 | 0.06 | 154 ± 20 | 146 ± 18 | 0.01 | Ow: 0.25, 8w: 0.05 |
DBP | 82 ± 13 | 79 ± 12 | 0.01 | 78 ± 12 | 75 ± 10 | 0.05 | Ow: 0.12, 8w: 0.08 |
Post-SBP (mmHg) | 133 ± 17 | 127 ± 20 | 0.01 | 128 ± 20 | 125 ± 15 | 0.17 | Ow: 0.21, 8w: 0.51 |
DBP | 70 ± 11 | 67 ± 13 | 0.02 | 70 ± 14 | 67 ± 13 | 0.06 | 0w:0.81, 8 W.0.79 |
Hb (g/dL) | 10.8 ± 0.9 | 10.8 ± 0.9 | 0.96 | 11.2 ± 0.9 | 10.7 ± 1.0 | 0.01 | Ow: 0.05 |
Pre-MPO (pg/mL) | 74.8 ± 58.5 | 74.2 ± 63.0 | 0.84 | 71.0 ± 46.7 | 68.5 ± 64.1 | 0.48 | 0w:0.72, 8w: 0.65 |
Post-MPO (pg/mL) | 307.7 ± 244.7 | 277.8 ± 217.1 | 0.28 | 244.8 ± 151.8 | 262.3 ± 229.6 | 0.34 | 0w:0.14, 8w: 0.73 |